Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.39 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.39 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.39 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.39 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.39 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.39 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.37 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | CDC25B | P30305 | 1/20 | 0.34 |
| ▸ | AKT1 | P31749 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30908525 | 1.00 | PIM1 (0.39) | PIM1CSNK1A1CDK5ROCK1DYRK1A | |
| SCHEMBL7502 | 0.81 | PARP10 (0.39) | PIM1CSNK1A1CDK5ROCK1DYRK1A | |
| SCHEMBL4404550 | 0.76 | MEN1 (0.50) | PARP10PARP11ACHECA1CA2 | |
| SCHEMBL18162627 | 0.76 | NOTUM (0.48) | PIM1ACHECA1CA2CA7 | |
| SCHEMBL254906 | 0.76 | MAOA (0.47) | ACHECA1CA2CA7CA9 | |
| SCHEMBL9171936 | 0.76 | MAPT (0.41) | ACHEIDO1MEN1KMT2AS100A4 | |
| Hydrochloric Acid SCHEMBL10513970 | 0.74 | MAPT (0.40) | ACHEIDO1MEN1KMT2AS100A4 | |
| SCHEMBL15039690 | 0.73 | ACHE (0.33) | ACHEMEN1KMT2AS100A4ALDH1A1 | |
| SCHEMBL20022731 | 0.72 | CES1 (0.41) | MEN1KMT2AALDH1A1 | |
| SCHEMBL30714317 | 0.71 | CDK5 (0.46) | PIM1CSNK1A1CDK5ROCK1DYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024074611-A1 | PRMT5 INHIBITORS | Ryvu Therapeutics S.A. (PL) | 2024-04-11 | — | — | WO | disclosed |
| US-10361377-B2 | Condensed cyclic compound and organic light emitting device including the same | SAMSUNG SDI CO., LTD. (KR) | 2019-07-23 | — | — | US | disclosed |
| US-20160308143-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-10-20 | — | — | US | disclosed |
| US-20160308143-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-10-20 | — | — | US | disclosed |
| US-20160308143-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-10-20 | — | — | US | disclosed |
| WO-2015108301-A1 | FUSED RING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 삼성에스디아이 주식회사 | 2015-07-23 | — | — | WO | disclosed |
| EP-2323978-A1 | AMIDE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010018874-A1 | AMIDE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-02-18 | — | — | WO | disclosed |
| US-20100041891-A1 | AMIDE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160308143-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | PIM1 3117/4885CSNK1A1 2747/4885CDK5 75/4885 |
| US-20100041891-A1 | AMIDE COMPOUND | GPR52, GPR132, NR5A2 | PIM1 3452/4885CSNK1A1 1256/4885CDK5 3927/4885 |
| US-10361377-B2 | Condensed cyclic compound and organic light emitting device including the same | CRY1, CRY2, CCNE2 | PIM1 3117/4885CSNK1A1 2747/4885CDK5 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.